19 - 20 November 2015 | Philadelphia, PA
At eyeforpharma's 3rd annual Customer Engagement Summit delegates will learn how to engage their key customers through a wide range of channels – from digital to F2F. More info here...

Wednesday, November 22, 2006

Lame-Duck Senate Roasts Eschenbach Turkey!

EyeOnFDA reports (see "Hold It!"):
"Senator Charles Grassley (R-Iowa) has gone and put a hold on the nomination of Dr. Andrew C. von Eschenbach. There was movement to try to get him approved in the lame-duck Senate session, but the hold would put that into doubt."

Interestingly, this is the third hold by Republicans classified as "political" vs. two Democratic holds classified as "legitimate" by my friend Mark Senak, author of EyeOnFDA:
"According to reports, this hold is rooted in concerns about the approval of Ketek, manufactured by Sanofi Aventis...other holds placed on this nomination were solely for political objectives - one regarding importation, one regarding abortion by Senators Vitter (R-Louisiana) and DeMint (R-S. Carolina), respectively."
For more on the Ketek issue, see "Celsius 3014: Ketek, Drug Safety, & Bioterrorism."

It appears that the von Eschenbach nomination is headed for turkeyville; I know I am.

Happy Thanksgiving!

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...